Current Research and Clinical Trials
Physicians at McGovern Medical School at UTHealth are engaged in a broad and intensive research program focused on the mechanisms, treatment and cure of neurological disease and injury. They use diverse approaches – molecular, transgenic and electrophysiological techniques – in biomedical studies, translational research, clinical trials and technology development and assessment.
Grants to researchers at UTHealth are awarded by the National Institutes of Health, the Vivian L. Smith Foundation for Neurologic Disease, the American Stroke Association and other granting agencies. Investigations cover major areas of neurological disease, including stroke, aneurysm, spinal cord injury, brain tumor, stem cell therapies, neuroprotection, hypoxic encephalopathy, epilepsy, traumatic brain injury and Parkinson’s disease.
Research funding for the Department of Neurology for the 2019-20 academic year exceeds $28.5 million, including grants and contracts. Research funding for the Vivian L. Smith Department of Neurosurgery for the same time period is more than $17.4 million, including grants and contracts. The following listing is a sample of ongoing or recently completed research projects.
See research trials by condition type by clicking an option below:
Epilepsy and Seizure Disorders
- Prevention Clinical Trials
- Recovery Trials
- Acute Ischemic Stroke Trials
- Acute Brain Hemorrhage Trials
- Subarachnoid Hemorrhage Trials
Clinical Trials
Please fill out the fields to receive information about an ongoing UTHealth Neurosciences clinical trial.